0% found this document useful (0 votes)
15 views2 pages

Share Appreciation Rights Accounting Guide

The document outlines various scenarios involving share appreciation rights (SARs) for an entity, detailing the compensation expenses and accrued liabilities for specific years based on predetermined prices and market values. It includes multiple-choice questions regarding the amounts to be reported as compensation expenses and gains on reversals for different years. The scenarios cover different cases of SARs granted to management and executives, with specific market prices provided for calculations.

Uploaded by

af7240618
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
15 views2 pages

Share Appreciation Rights Accounting Guide

The document outlines various scenarios involving share appreciation rights (SARs) for an entity, detailing the compensation expenses and accrued liabilities for specific years based on predetermined prices and market values. It includes multiple-choice questions regarding the amounts to be reported as compensation expenses and gains on reversals for different years. The scenarios cover different cases of SARs granted to management and executives, with specific market prices provided for calculations.

Uploaded by

af7240618
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

CPA REVIEW SCHOOL OF THE PHILIPPINES

Manila

FINANCIAL ACCOUNTING AND REPORTING VALIX/VALIX/ESCALA/SANTOS/DELA CRUZ


BATCH 92 OCTOBER 2022 CPALE
SHARE APPRECIATION RIGHTS
1. On January 1, 2022, an entity offered management share appreciation rights equal to 50,000 shares with
a predetermined price of P100. The service period is 3 years and the exercise date is January 1, 2025. The
quoted prices per share are P124 on December 31, 2022, P151 on December 31, 2023 and P155 on
December 31, 2024.
1. What amount should be reported as compensation expense for 2022?
a. 1,200,000
b. 1,100,000
c. 400,000
d. 600,000
2. What amount should be reported as compensation expense for 2023?
a. 1,700,000
b. 2,550,000
c. 1,300,000
d. 1,000,000
3. What amount should be charged to compensation expense for 2024?
a. 2,750,000
b. 1,300,000
c. 1,050,000
d. 1,450,000
4. What amount should be recognized as gain on reversal of share appreciation rights in 2023 if the
market price dropped to P120 on December 31, 2023?
a. 1,000,000
b. 1,700,000
c. 700,000
d. 0
2. An entity granted 30,000 share appreciation rights which entitled key employees to receive cash equal to
the difference between P200 and the market price of the share on the date each right is exercised. The
service period is 2022 through 2024 and the rights are exercisable in 2025. The market price of the share
was P250 and P280 on December 31, 2022 and 2023, respectively.
What amount should be reported as accrued liability on December 31, 2023?
a. 2,400,000
b. 1,300,000
c. 1,600,000
d. 1,100,000
3. On January 1, 2022, an entity granted the president 80,000 share appreciation rights for past services. The
rights are exercisable immediately and expire on December 31, 2023. On exercise, the president is
entitled to receive cash for the excess of the share market price on exercise date over the market price on
grant date. The president did not exercise any of the rights in 2022. The market price of the share was
P100 on January 1, 2022 and P125 on December 31, 2022. The president exercised the rights on
December 31, 2023 when the market price was P110.
1. What amount should be reported as compensation expense for 2022?
a. 2,000,000
b. 1,000,000
c. 500,000
d. 250,000
2. What amount should be recognized as gain on reversal of share appreciation rights in 2023?
a. 1,200,000
b. 1,000,000
c. 800,000
d. 400,000

7071
Page 2
4. On January 1, 2022, an entity issued share appreciation rights to its president exercisable for one year
beginning January 1, 2025 provided that the president is still in the employ of the company at that date
of exercise. Each right provides for a cash payment equal to the excess of the entity’s share price over
P50. The equivalent number of shares for share appreciation rights will be based on the level of sales at
the date of exercise. The actual sales achieved totaled P3,500,000 in 2022, P5,500,000 in 2023 and
P6,500,000 in 2024. The equivalent number of shares is 10,000 if the level of sales is P2,000,000 to
P4,000,000 and 15,000 if the level of sales is over P4,000,000 and 20,000 shares if the level of sales is
P6,500,000. The share prices are P86 in 2022, P95 in 2023 and P105 in 2024.
1. What amount should be reported as compensation expense for 2022?
a. 360,000
b. 120,000
c. 180,000
d. 160,000
2. What amount should be reported as compensation expense for 2023?
a. 675,000
b. 330,000
c. 250,000
d. 450,000
3. What amount should be reported as compensation expense for 2024?
a. 850,000
b. 770,000
c. 650,000
d. 425,000
5. On January 1, 2022, an entity established a share appreciation rights plan for the executives. The plan
entitled them to receive cash at any time during the next four years for the difference between the market
price of the ordinary share and a pre-established price of P20 on 60,000 share appreciation right or SARs.
On December 31, 2024, 20,000 SARs are exercised by executives. The market prices per share are P28
on December 31, 2022, P35 on December 31, 2023 and P30 on December 31, 2024.
1. What amount should be reported as compensation expense for 2022?
a. 480,000
b. 120,000
c. 300,000
d. 180,000
2. What amount of compensation expense should be recognized for 2023?
a. 900,000
b. 420,000
c. 105,000
d. 225,000
3. What amount should be recognized as gain on reversal of SARs in 2024?
a. 500,000
b. 300,000
c. 100,000
d. 0
4. What amount should be reported as accrued compensation on December 31, 2024?
a. 400,000
b. 900,000
c. 600,000
d. 200,000

End

7071

Common questions

Powered by AI

A change in market price directly correlates to the gain or loss recognition for share appreciation rights. If the market price increases compared to the predetermined price set for the SARs, it results in a compensation expense, as the value to fulfill these rights increases. Conversely, if the market price decreases, this can lead to the recognition of a gain as previous estimates of compensation can be reversed. For example, if the market price falls to P120 from a higher value, the entity may recognize a gain on the reversal of SARs .

The service period influences the reporting of compensation expenses related to SARs by dictating how expenses are distributed across the reporting periods. The expense attributable to SARs is typically allocated over the vesting period, which is the span from the grant date until the rights become exercisable (the service period). This ensures that the expense recognition reflects the period of employee services contributing to the right to exercise SARs. For example, if the service period is three years, expenses will be allocated proportionally over these years based on the increase in value of the SARs during these times .

The complexity in calculating accrued liability for SARs at the end of a reporting period arises from multiple factors, including fluctuations in share price, the extent of the service period completed, expected future market performance, the number of rights expected to vest, and the level of employee participation. For accurate accrual, companies must estimate these variables as of the reporting date. For instance, if a share price rises significantly by year-end, coupled with more vested rights, the accrued liability will increase proportionally .

Share appreciation rights offer strategic advantages by providing financial incentives tied directly to company performance, aligning employee interests with those of shareholders. By offering value contingent on future price increases, SARs motivate employees towards enhancing company performance, contributing to retention by rewarding loyalty through incremental rights vesting over time. Employees perceive SARs as having a tangible potential reward, motivating continued association and performance improvement, fostering a performance-oriented workplace culture .

SARs valuation based on actual sales differences and market price ranges is crucial for accurate financial reporting as it determines the number of equivalent shares and thus influences the compensation expense. Valuation linked to sales ensures that share allocation aligns with entity performance, creating a transparent link between company success and employee compensation incentives. For example, a sales threshold system allocates more shares with increasing sales above certain brackets, reflecting in increased valuation and reported expenses if benchmarks are achieved .

Share appreciation rights (SARs) impact a company's compensation expenses in that the compensation expense recognized in each year is based on the changes in the market price of the shares over the service period until the exercise date. The expense for a given year is typically calculated using the value of the SARs granted reduced by the predetermined exercise price, apportioned over the service period. For example, in the case where SARs are tied to a three-year service period with exercise dates, the company must reassess the value of SARs each year based on market prices (e.g., P124, P151, and P155 in respective years) and adjust the compensation expense accordingly .

The significance of share price changes in determining compensation expenses for SARs is that it directly affects the valuation of the SARs, which are based on the excess of the market price over the exercise price. As the market price increases, the value of SARs and thereby the compensation expense increase as well, requiring the company to accrue higher expenses. Conversely, if the market price declines, the company might reverse some of the recognized compensation expenses due to the decreased liability. For instance, in 2023, if the market price drops, the gain recognized could be due to reversing part of the previously recorded expenses .

An entity can adjust its fiscal planning by closely monitoring anticipated compensation expenses from SARs, allowing for timely allocation of funds or adjustments in operational budgets to buffer against increased liabilities. With alloted expenses contingent on market performance, strategic forecasting becomes critical, guiding decisions such as cash reserve allocations or investment strategies to counterbalance increased SAR liabilities. Additionally, entities may also consider modifying SAR grant terms to mitigate financial impacts or aligning employee targets with broader strategic goals to optimize anticipated outlay efficiency .

For an immediate service period, the entire cost related to the market price increase of SARs from P100 to P125 should be recognized as compensation expense in the year of grant if the rights are exercisable immediately. Therefore, (P125 - P100) x number of rights equals the compensation expense. Specifically, if 80,000 rights were granted, the expense would be 80,000 x (125 - 100) = P2,000,000 .

A gain on reversal of share appreciation rights is determined when the liability previously recognized as compensation expense due to SARs is reversed, typically due to a decrease in market price or when the expected conditions for exercise are not met. This reversal effectively releases previously allocated funds back to the company's financial position, indicating a reduced liability and improving short-term liquidity. For instance, if the market price decreases below what was originally estimated, the reversal signifies decreased anticipated payouts, reflecting positively on financial health .

You might also like